BeiGene Ltd ADR buy Guggenheim
Start price
28.02.23
/
50%
€214.00
Target price
28.02.24
€329.84
Performance (%)
-26.17%
End price
29.02.24
€158.00
Summary
This prediction ended on 29.02.24 with a price of €158.00. The price of BeiGene Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.17%. Guggenheim has a follow-up prediction for BeiGene Ltd ADR where he still thinks BeiGene Ltd ADR is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | -5.797% | -5.797% | -45.833% |
| iShares Core DAX® | -2.196% | -0.532% | 12.492% |
| iShares Nasdaq 100 | -0.074% | 1.843% | 40.598% |
| iShares Nikkei 225® | -2.154% | -1.109% | 22.295% |
| iShares S&P 500 | -0.501% | 1.475% | 28.278% |
Comments by Guggenheim for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $350.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for BeiGene Ltd ADR
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€166.00
27.02.24
27.02.24
€317.85
27.02.25
27.02.25
-24.10%
16.04.24
16.04.24
